相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Induction of ATM/ATR pathway combined with Vγ2Vδ2 T cells enhances cytotoxicity of ovarian cancer cells
Jingwei Lu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Antibody-modified T cells: CARs take the front seat for hematologic malignancies
Marcela V. Maus et al.
BLOOD (2014)
Endothelial cell protein C receptor: a multiliganded and multifunctional receptor
L. Vijaya Mohan Rao et al.
BLOOD (2014)
Targeted Activation of Human Vγ9Vδ2-T Cells Controls Epstein-Barr Virus-Induced B Cell Lymphoproliferative Disease
Zheng Xiang et al.
CANCER CELL (2014)
Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer Cells
Hans-Heinrich Oberg et al.
CANCER RESEARCH (2014)
Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood γδ T cells
Shirin Kalyan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Cytomegalovirus drives V2neg T cell inflation in many healthy virus carriers with increasing age
A. Alejenef et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Activating and Propagating Polyclonal Gamma Delta T Cells with Broad Specificity for Malignancies
Drew C. Deniger et al.
CLINICAL CANCER RESEARCH (2014)
Neuroblastoma Killing Properties of Vδ2 and Vδ2-Negative γδT Cells Following Expansion by Artificial Antigen-Presenting Cells
Jonathan P. H. Fisher et al.
CLINICAL CANCER RESEARCH (2014)
Vγ9Vδ2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6
Felipe Riano et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
CD8αα+ Innate-Type Lymphocytes in the Intestinal Epithelium Mediate Mucosal Immunity
Luc Van Kaer et al.
IMMUNITY (2014)
The Identification of the Endogenous Ligands of Natural Killer T Cells Reveals the Presence of Mammalian α-Linked Glycosylceramides
Lisa Kain et al.
IMMUNITY (2014)
The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells
Andrew Sandstrom et al.
IMMUNITY (2014)
Vγ9 and Vδ2 T cell antigen receptor genes and butyrophilin 3 (BTN3) emerged with placental mammals and are concomitantly preserved in selected species like alpaca (Vicugna pacos)
Mohindar M. Karunakaran et al.
IMMUNOGENETICS (2014)
Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVγ9+ γδ T lymphocytes
Emilie Decaup et al.
IMMUNOLOGY LETTERS (2014)
Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma
Jiuwei Cui et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The TCR ligand-inducible expression of CD73 marks γδ lineage commitment and a metastable intermediate in effector specification
Francis Coffey et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
The molecular bases of δ/αβ T cell-mediated antigen recognition
Daniel G. Pellicci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
A novel self-lipid antigen targets human T cells against CD1c+ leukemias
Marco Lepore et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
Martin Wilhelm et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
CD1d expression is higher in chronic lymphocytic leukemia patients with unfavorable prognosis
Agnieszka Bojarska-Junak et al.
LEUKEMIA RESEARCH (2014)
Enforcement of γδ-lineage commitment by the pre-T-cell receptor in precursors with weak γδ-TCR signals
Payam Zarin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The CD3 Conformational Change in the γδ T Cell Receptor Is Not Triggered by Antigens but Can Be Enforced to Enhance Tumor Killing
Elaine P. Dopfer et al.
CELL REPORTS (2014)
Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
Ikuo Wada et al.
CANCER MEDICINE (2014)
Natural killer T cell strategies to combat Epstein-Barr virus infection
John J. Priatel et al.
ONCOIMMUNOLOGY (2014)
Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells
Tomoharu Sugie et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
A novel antibody-like TCRγδ-Ig fusion protein exhibits antitumor activity against human ovarian carcinoma
Jing Zheng et al.
CANCER LETTERS (2013)
Comparison of T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid
Atif S. M. Idrees et al.
CANCER SCIENCE (2013)
gamma delta-T cells: an unpolished sword in human anti-infection immunity
Jian Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain
Takamichi Izumi et al.
CYTOTHERAPY (2013)
Crystal Structure of Vδ1 T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human γδ T Cells
Adrienne M. Luoma et al.
IMMUNITY (2013)
Human V2V2 T cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors
Reeva Aggarwal et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Vav1-phospholipase C-γ1 (Vav1-PLC-γ1) Pathway Initiated by T Cell Antigen Receptor (TCRγδ) Activation Is Required to Overcome Inhibition by Ubiquitin Ligase Cbl-b during γδT Cell Cytotoxicity
Shanshan Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Monocytes and γδ cells control the acute-phase response to intravenous zoledronate: Insights from a phase IV safety trial
Joanne L. Welton et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Cutting Edge: CD1d Restriction and Th1/Th2/Th17 Cytokine Secretion by Human Vδ3 T Cells
Bozgana A. Mangan et al.
JOURNAL OF IMMUNOLOGY (2013)
Essential Requirements of Zoledronate-Induced Cytokine and gamma delta T Cell Proliferative Responses
Oliver Nussbaumer et al.
JOURNAL OF IMMUNOLOGY (2013)
Butyrophilin 3A1 Plays an Essential Role in Prenyl Pyrophosphate Stimulation of Human V gamma 2V delta 2 T Cells
Hong Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia
W. Scheper et al.
LEUKEMIA (2013)
Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor
Drew C. Deniger et al.
MOLECULAR THERAPY (2013)
The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture
Alexander Hoh et al.
LIVER INTERNATIONAL (2013)
Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection
Jia Zhu et al.
NATURE (2013)
Evolutionary implications of a third lymphocyte lineage in lampreys
Masayuki Hirano et al.
NATURE (2013)
Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy
Maria Themeli et al.
NATURE BIOTECHNOLOGY (2013)
Monoclonal T-cell receptor drugs pique pharma's interest
Cormac Sheridan
NATURE BIOTECHNOLOGY (2013)
CD1d-lipid antigen recognition by the γδ TCR
Adam P. Uldrich et al.
NATURE IMMUNOLOGY (2013)
Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells
Stefano Vavassori et al.
NATURE IMMUNOLOGY (2013)
Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
Lawrence S. Lamb et al.
PLOS ONE (2013)
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell- Mediated Cytotoxicity
Matilde Todaro et al.
PLOS ONE (2013)
CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vδ1+γδ T Cells
Andrea Knight et al.
PLOS ONE (2013)
New prospects on the NKG2D/NKG2DL system for oncology
Evelyn Ullrich et al.
ONCOIMMUNOLOGY (2013)
Human MHC Class I-restricted high avidity CD4(+) T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo
Shao-An Xue et al.
ONCOIMMUNOLOGY (2013)
Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa)
Lionel Couzi et al.
BLOOD (2012)
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells
Marta Coscia et al.
BLOOD (2012)
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset
Christelle Harly et al.
BLOOD (2012)
Long-Term Effects of Amino-Bisphosphonates on Circulating γδ T Cells
Maurizio Rossini et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
CDR3δ-grafted γ9δ2T cells mediate effective antitumor reactivity
Hui Zhao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies
Jianhua Zhou et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
In Vivo Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Trigger Vγ9Vδ2 T-cell Antitumor Cytotoxicity through ICAM-1 Engagement
Ismahene Benzaid et al.
CLINICAL CANCER RESEARCH (2012)
Coreceptor gene imprinting governs thymocyte lineage fate
Stanley Adoro et al.
EMBO JOURNAL (2012)
The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR
Li Bai et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Different affinity windows for virus and cancer-specific T-cell receptors: Implications for therapeutic strategies
Milos Aleksic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response
Hassnae Afrache et al.
IMMUNOGENETICS (2012)
The molecular determinants of CD8 co-receptor function
David K. Cole et al.
IMMUNOLOGY (2012)
Effects of hyperthermia on Hsp27 (HSPB1), Hsp72 (HSPA1A) and DNA repair proteins hMLH1 and hMSH2 in human colorectal cancer hMLH1-deficient and hMLH1-proficient cell lines
Silvina B. Nadin et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2012)
The Molecular Basis for Modulation of Human Vγ9Vδ2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies
Aparna Palakodeti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Ectopically Expressed Human Tumor Biomarker MutS Homologue 2 Is a Novel Endogenous Ligand That Is Recognized by Human γδT Cells to Induce Innate Anti-tumor/Virus Immunity
Yumei Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Ectopic Expression of Human MutS Homologue 2 on Renal Carcinoma Cells Is Induced by Oxidative Stress with Interleukin-18 Promotion via p38 Mitogen-activated Protein Kinase (MAPK) and c-Jun N-terminal Kinase (JNK) Signaling Pathways
Chen Mo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy: Results From a Prospective Phase I/II Trial
Volker Kunzmann et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor
Carrie R. Willcox et al.
NATURE IMMUNOLOGY (2012)
Intrathymic programming of effector fates in three molecularly distinct γδ T cell subtypes
Kavitha Narayan et al.
NATURE IMMUNOLOGY (2012)
Monoclonal TCR-redirected tumor cell killing
Nathaniel Liddy et al.
NATURE MEDICINE (2012)
Targeting tumor cell metabolism with statins
J. W. Clendening et al.
ONCOGENE (2012)
MHC restriction is imposed on a diverse T cell receptor repertoire by CD4 and CD8 co-receptors during thymic selection
Francois Van Laethem et al.
TRENDS IN IMMUNOLOGY (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Redirecting αβT cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor
Victoria Marcu-Malina et al.
BLOOD (2011)
Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
A. J. Nicol et al.
BRITISH JOURNAL OF CANCER (2011)
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
Joshua M. Lang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Zoledronate-activated V gamma 9 gamma delta T cell-based immunotherapy is feasible and restores the impairment of gamma delta T cells in patients with solid tumors
Atsutaka Noguchi et al.
CYTOTHERAPY (2011)
Indirect Stimulation of Human Vγ2Vδ2 T Cells through Alterations in Isoprenoid Metabolism
Hong Wang et al.
JOURNAL OF IMMUNOLOGY (2011)
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
Michael Gnant et al.
LANCET ONCOLOGY (2011)
Skint-1 is a highly specific, unique selecting component for epidermal T cells
Susannah D. Barbee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Crystal structure of γδ T-cell receptor specific for the human MHC class I homolog MICA
Bin Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Therapeutic Targeting of the DNA Mismatch Repair Pathway
Sarah A. Martin et al.
CLINICAL CANCER RESEARCH (2010)
F1-Adenosine Triphosphatase Displays Properties Characteristic of an Antigen Presentation Molecule for Vγ9Vδ2 T Cells
Jayati Mookerjee-Basu et al.
JOURNAL OF IMMUNOLOGY (2010)
Cytomegalovirus-Induced gamma delta T Cells Associate with Reduced Cancer Risk after Kidney Transplantation
Lionel Couzi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
Gareth J. Morgan et al.
LANCET (2010)
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
Gavin M. Bendle et al.
NATURE MEDICINE (2010)
Mixed T cell receptor dimers harbor potentially harmful neoreactivity
Marleen M. van Loenen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Dysregulation of the mevalonate pathway promotes transformation
James W. Clendening et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The NKG2D ligand ULBP4 binds to TCRγ9/δ2 and induces cytotoxicity to tumor cells through both TCRγδ and NKG2D
Yan Kong et al.
BLOOD (2009)
Adoptive immunotherapy of lung cancer with immobilized anti-TCRγδ antibody-expanded human γδ T-cells in peripheral blood
Ning Kang et al.
CANCER BIOLOGY & THERAPY (2009)
gamma delta T cells develop independently of Aire
Heli Tuovinen et al.
CELLULAR IMMUNOLOGY (2009)
Rapid αβ TCR-mediated responses in γδ T cells transduced with cancer-specific TCR genes
A. Hiasa et al.
GENE THERAPY (2009)
alpha beta T Cell Receptor Transfer to gamma delta T Cells Generates Functional Effector Cells without Mixed TCR Dimers In Vivo
Lars T. van der Veken et al.
JOURNAL OF IMMUNOLOGY (2009)
Harnessing invariant NKT cells in vaccination strategies
Vincenzo Cerundolo et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Identification of human T cell receptor γδ-recognized epitopes/proteins via CDR3δ peptide-based immunobiochemical strategy
Hui Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Deletion of CD4 and CD8 coreceptors permits generation of αβT cells that recognize antigens independently of the MHC
Frangois Van Laethem et al.
IMMUNITY (2007)
Human TCR-Binding affinity is governed by MHC class restriction
David K. Cole et al.
JOURNAL OF IMMUNOLOGY (2007)
CD1-restricted recognition of exogenous and self-lipid antigens by duodenal γδ plus T lymphocytes
Anna M. Russano et al.
JOURNAL OF IMMUNOLOGY (2007)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
αβ T-cell receptor engineered γδ T cells mediate effective antileukemic reactivity
LT van der Veken et al.
CANCER RESEARCH (2006)
Strength of signal: a fundamental mechanism for cell fate specification
SM Hayes et al.
IMMUNOLOGICAL REVIEWS (2006)
Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface
L Wooldridge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Professional antigen-presentation function by human γδ T cells
M Brandes et al.
SCIENCE (2005)
Shared reactivity of V δ2neg γδ T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells
F Halary et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Tumor recognition following V gamma 9V delta 2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I
E Scotet et al.
IMMUNITY (2005)
The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gamma delta T cells in response to aminobisphosphonates is inhibited by statins
RE Hewitt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
The evolutionary and structural 'logic' of antigen receptor diversity
MM Davis
SEMINARS IN IMMUNOLOGY (2004)
Recognition of nonpeptide antigens by human Vγ9Vδ2 T cells requires contact with cells of human origin
AE Green et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation
PD Holler et al.
IMMUNITY (2003)
Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells
HJ Gober et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The crystal structure of the endothelial protein C receptor and a bound phospholipid
V Oganesyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of cutaneous malignancy by γδ T cells
M Girardi et al.
SCIENCE (2001)
The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor ζ chain
MA Purbhoo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)